# Chan Zuckerberg Biohub San Francisco

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/chan-zuckerberg-biohub-san-francisco/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 71.4 |
| Citations | 10,161 |
| City | San Francisco |
| Country | United States |
| Description | Chan Zuckerberg Biohub San Francisco is a research organisation in San Francisco, United States. OpenAlex records 1,072 works and 10,161 citations for it. 5 researchers list it as their most recent affiliation. |
| Homepage | https://www.czbiohub.org/sf/ |
| OpenAlex ID | https://openalex.org/I4210100286 |
| Researchers | 5 |
| ROR ID | https://ror.org/00knt4f32 |
| Type | facility |
| Works | 1,072 |

## University papers

- [BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis](https://scholariq.org/papers/bay-43-9006-exhibits-broad-spectrum-oral-antitumor-activity-and-targets-the-raf/)
- [Association of reactive oxygen species levels and radioresistance in cancer stem cells](https://scholariq.org/papers/association-of-reactive-oxygen-species-levels-and-radioresistance-in-cancer-stem/)
- [Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS](https://scholariq.org/papers/mutations-in-prion-like-domains-in-hnrnpa2b1-and-hnrnpa1-cause-multisystem/)
- [<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors](https://scholariq.org/papers/i-ras-i-mutations-in-cutaneous-squamous-cell-carcinomas-in-patients-treated-with/)
- [Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways](https://scholariq.org/papers/exome-sequencing-in-amyotrophic-lateral-sclerosis-identifies-risk-genes-and/)
- [Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection](https://scholariq.org/papers/circulating-cell-free-dna-enables-noninvasive-diagnosis-of-heart-transplant/)
- [Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines](https://scholariq.org/papers/single-cell-profiling-of-circulating-tumor-cells-transcriptional-heterogeneity/)
- [The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner](https://scholariq.org/papers/the-raf-inhibitor-plx4032-inhibits-erk-signaling-and-tumor-cell-proliferation-in/)
- [Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages](https://scholariq.org/papers/senescent-cells-promote-tissue-nad-decline-during-ageing-via-the-activation-of/)
- [Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation](https://scholariq.org/papers/small-molecule-mapk-inhibitors-restore-radioiodine-incorporation-in-mouse/)
- [CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia](https://scholariq.org/papers/ccnf-mutations-in-amyotrophic-lateral-sclerosis-and-frontotemporal-dementia/)

## University researchers

- [Stephen R. Quake](https://scholariq.org/researchers/stephen-r-quake/)
- [Yasin Şenbabaoğlu](https://scholariq.org/researchers/yasin-senbabaoglu/)
- [Zeming Lin](https://scholariq.org/researchers/zeming-lin/)
- [Gideon Bollag](https://scholariq.org/researchers/gideon-bollag/)
- [Aaron D. Gitler](https://scholariq.org/researchers/aaron-d-gitler/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.